Literature DB >> 25968651

[Research on humans suffering from dementia].

H Helmchen1.   

Abstract

The urgent necessity for dementia research is justified by the prevalence and increase in dementia associated with the demographic changes, for which no causal treatment is available; however, during the progressive course dementia destroys the capacity for self-determination of persons affected and thereby an essential prerequisite for participation in research, i.e. a valid consent to a research intervention. Accordingly, not only sufficient information about all issues which are relevant for decision making by potential participants but also a flawless assessment of the capacity to consent are important; however, currently this is not satisfactorily possible. This article attempts to answer questions associated with these problems, such as how consent can be established, including that of a surrogate for consent of potential research participants by whom consent is no longer possible. In a second section the benefit-risk evaluation, which is also underdeveloped, will be dealt with using two concrete research examples, a diagnostic and a therapeutic research intervention for patients with dementia.

Entities:  

Mesh:

Year:  2015        PMID: 25968651     DOI: 10.1007/s00115-015-4302-0

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  31 in total

Review 1.  Convention for the Protection of Human Rights and Dignity of the Human Being with Regard to the Application of Biology and Medicine: Convention on Human Rights and Biomedicine.

Authors: 
Journal:  J Med Philos       Date:  2000-04

Review 2.  Inclusion of patients with severe mental illness in clinical trials: issues and recommendations surrounding informed consent.

Authors:  Sander P K Welie; Ron L P Berghmans
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

3.  Comparison of two enhanced consent procedures for patients with mild Alzheimer disease or mild cognitive impairment.

Authors:  Dinesh Mittal; Barton W Palmer; Laura B Dunn; Reid Landes; Courtney Ghormley; Cornelia Beck; Shah Golshan; Dean Blevins; Dilip V Jeste
Journal:  Am J Geriatr Psychiatry       Date:  2007-02       Impact factor: 4.105

4.  Violence and leveraged community treatment for persons with mental disorders.

Authors:  Jeffrey W Swanson; Richard A Van Dorn; John Monahan; Marvin S Swartz
Journal:  Am J Psychiatry       Date:  2006-08       Impact factor: 18.112

5.  The world of dementia beyond 2020.

Authors:  Henry Brodaty; Monique M B Breteler; Steven T Dekosky; Pascale Dorenlot; Laura Fratiglioni; Christoph Hock; Paul-Ariel Kenigsberg; Philip Scheltens; Bart De Strooper
Journal:  J Am Geriatr Soc       Date:  2011-04-13       Impact factor: 5.562

6.  Beneficial effect of human anti-amyloid-beta active immunization on neurite morphology and tau pathology.

Authors:  Alberto Serrano-Pozo; Christopher M William; Isidro Ferrer; Emmanuelle Uro-Coste; Marie-Bernadette Delisle; Claude-Alain Maurage; Christoph Hock; Roger M Nitsch; Eliezer Masliah; John H Growdon; Matthew P Frosch; Bradley T Hyman
Journal:  Brain       Date:  2010-03-31       Impact factor: 13.501

7.  Neuropsychological correlates of capacity determinations in Alzheimer disease: implications for assessment.

Authors:  Barton W Palmer; Kerry A Ryan; H Myra Kim; Jason H Karlawish; Paul S Appelbaum; Scott Y H Kim
Journal:  Am J Geriatr Psychiatry       Date:  2013-01-11       Impact factor: 4.105

8.  Medical decision-making capacity in patients with mild cognitive impairment.

Authors:  O Okonkwo; H R Griffith; K Belue; S Lanza; E Y Zamrini; L E Harrell; J C Brockington; D Clark; R Raman; D C Marson
Journal:  Neurology       Date:  2007-10-09       Impact factor: 9.910

9.  Proxies and consent discussions for dementia research.

Authors:  Jeremy Sugarman; Debra Roter; Carole Cain; Roberta Wallace; Don Schmechel; Kathleen A Welsh-Bohmer
Journal:  J Am Geriatr Soc       Date:  2007-04       Impact factor: 5.562

10.  How do institutional review boards apply the federal risk and benefit standards for pediatric research?

Authors:  Seema Shah; Amy Whittle; Benjamin Wilfond; Gary Gensler; David Wendler
Journal:  JAMA       Date:  2004-01-28       Impact factor: 56.272

View more
  1 in total

Review 1.  [Advance directive of probands in pharmaceutical research : A medical ethics discussion].

Authors:  M Haupt; F Jessen; H Fangerau
Journal:  Nervenarzt       Date:  2018-03       Impact factor: 1.214

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.